Please wait a minute...
文章检索
预防医学  2018, Vol. 30 Issue (9): 893-896    DOI: 10.19485/j.cnki.issn2096-5087.2018.09.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
金华市结核病患者耐药情况分析
张子根,郑浩,章光明
金华市疾病预防控制中心,浙江 金华 321002
Drug resistance of tuberculosis patients in Jinhua
ZHANG Zi-gen,ZHENG Hao,ZHANG Guang-ming
Jinhua Center for Disease Control and Prevention,Jinhua,Zhejiang 321002,China
全文: PDF(445 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解金华市结核病患者的耐药情况,为个体化治疗和耐药结核控制提供依据。方法 对2015年7月1日—2016年6月30日金华市结核病定点医院报告的结核病患者痰标本进行菌型鉴定,对培养阳性并鉴定为结核分枝杆菌的标本进行药敏试验,分析其耐药率、耐药类型和耐药谱。结果 痰培养共获得菌株939株,鉴定为结核分枝杆菌869株,占92.55%。869例结核分枝杆菌培养阳性患者中,耐药168例,总耐药率为19.33%;耐药谱系比例最高为链霉素(4.60%),最低为乙胺丁醇(0.23%)。初治患者802例,复治患者67例;复治患者总耐药率、耐多药率和单耐药率分别为58.21%、29.85%和25.37%,均高于初治患者的16.08%、3.24%和10.22%(P<0.05);初治患者耐药率较高的为链霉素(4.36%)、异胭肼(3.24%)和氧氟沙星(1.62%);复治患者耐药率较高的为利福平+异胭肼(14.93%)、异胭肼(11.94%)、链霉素(7.46%)、利福平+异胭肼+乙胺丁醇+链霉素(5.97%)和氧氟沙星(4.48%)。结论 金华市结核病患者总耐药率为19.33%,且复治患者耐药情况比初治患者严重。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张子根,郑浩,章光明
关键词 肺结核耐药初治复治    
AbstractObjective To understand the drug resistance of pulmonary tuberculosis(TB)patients in Jinhua and provide scientific basis for individualized treatment and the effective control of drug resistant TB. Methods The sputum specimens from TB patients reported in Jinhua TB hospital from July 1,2015 to June 30,2016 were identified. The drug sensitivity test was carried out for the specimens with positive culture and identified as Mycobacterium TB. The drug resistance rate,drug resistance type and drug resistance spectrum of the patients were analyzed. Results A total of 939 strains were obtained,and 869 strains were identified as Mycobacterium TB,accounting for 92.55%. Among the 869 TB patients,there were 168 cases of drug resistance,and the total resistance rate was 19.33%. The highest proportion of resistance spectrum was streptomycin(4.60%),and the lowest was ethambutol(0.23%). Of 869 TB patients,802 cases were first treated and 67 cases were retreated. The total resistance rate,multiple drug resistance rate and single drug resistance rate of the retreated patients were 58.21%,29.85% and 25.37%,which were higher than 16.08%,3.24% and 10.22% of the first treated patients (P<0.05). The drug resistance spectrum of the first treated patients was streptomycin(4.36%),isoniazide(3.24%)and ofloxacin(1.62%). The drug resistance spectrum of the retreated patients was rifampicin + isaziazide(14.93%),isoniazide(11.94%),streptomycin(7.46%),rifampicin + isaziazide + amethybutanol + streptomycin(5.97%)and ofloxacin(4.48%). Conclusion The total resistance rate of TB patients in Jinhua was 19.33%,and drug resistance in retreated patients was more severe than that in first treated patients.
Key wordsTuberculosis    Drug resistance    Initial treatment    Retreatment
     出版日期: 2018-09-04
ZTFLH:  R521  
通信作者: 张子根,E-mail:jhcdczzg@126.com   
作者简介: 张子根,本科,主任医师,主要从事结核病和麻风防制工作
引用本文:   
张子根,郑浩,章光明. 金华市结核病患者耐药情况分析[J]. 预防医学, 2018, 30(9): 893-896.
ZHANG Zi-gen,ZHENG Hao,ZHANG Guang-ming. Drug resistance of tuberculosis patients in Jinhua. Preventive Medicine, 2018, 30(9): 893-896.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2018.09.007      或      http://www.zjyfyxzz.com/CN/Y2018/V30/I9/893
[1] 杜娟,严重耐多药结核病的流行现状、防控难点及对策[J] .医学研究杂志,2010,39(8):17-21.
[2] WU B,ZHANG L,LIU Z,et al. Drug-resistant tuberculosis in Zhejiang Province,China:an updated analysis of time trends,1999-2013[J] . Glob Health Action,2017,10(1):e1293925.
[3] 中国防痨协会基础专业委员会. 结核病诊断实验室检验规程[M] . 北京:中国教育文化出版社,2006:13-56.
[4] 李清春,吴敏,陆敏,等. 浙江省杭州市肺结核患者耐药监测结果分析[J] . 疾病监测,2014,29(3):210-214.
[5] 全国第五次结核病流行病学抽样技术指导组. 2010年全国第五次结核病流行病学抽样调查报告[J] . 中国防痨杂志,2012,34(8):485-508.
[6] 陈松华,吴蓓蓓,柳正卫,等. 浙江省结核病耐药状况分析[J] . 预防医学,2016,28(8):757-761.
[7] COHEN T,MURRAY M. Incident tuberculosis among recent US immigrants and exogenous reinfection[J] . Emerg Infect Dis,2005, 11(5):725-728.
[8] 于梅,车洋,平国华,等. 2007年至2010年宁波市结核病耐药趋势及影响因素[J] . 中华传染病杂志,2012,30(1):48-52.
[9] LIU Q,ZHU LM,SHAO Y,et al. Rates and risk factor for drug resistence tuberculosis in northeastern China[J] . BMC Public Health,2013,13:1171.
[10] ALENA S,HENADZ H,AKSANA Z,et al. Multidrug- resistenttuberculosis in Belarus:the size of the problem and associated risk factor[J] . Bull World Organ,2013,91:36-45.
[11] 朱建福,王伟炳,王学才,等. 德清县耐药肺结核流行情况及危险因素研究[J] . 浙江预防医学,2009,21(9):6-8.
[12] 梅建,沈鑫,沈梅,等. 上海市结核分枝杆菌耐药性监测研究报告[J] . 中国防痨杂志,2007,29(5):395-397.
[13] 潘稚芬,高跃中,刘加良,等. 嘉兴市耐多药肺结核筛查结果分析[J] . 预防医学,2016,28(8):821-824.
[14] 王,石小俊,张幼萍,等. 114株结核分枝杆菌耐药性分析[J] . 预防医学,2016,28(11):1131-1132,1135.
[15] World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis[M] . Geneva:World Health Organization,2011.
[16] 车洋,于梅,平国华,等. 宁波地区2010—2011年结核病耐药监测结果及影响因素分析[J] . 中国卫生检验杂志,2013,23(2):495-497.
[17] 王敏,郝晓刚,郑夏雯.衢州市2010—2013年涂阳肺结核耐药状况分析[J] .浙江预防医学,2014,26(1):61-63.
[1] 毛照明, 郭新平, 杨慧玲, 王凯钫, 王安辉. 2005—2017年山阳县肺结核流行特征分析[J]. 预防医学, 2019, 31(7): 709-711.
[2] 胡玉琴, 章乐怡, 李毅, 谢爱蓉, 楼辉煌, 张彬. 温州市沙门菌血清型、耐药性和PFGE指纹图谱研究[J]. 预防医学, 2019, 31(6): 640-642.
[3] 王荣, 杨晨, 丁松宁, 苗瑞芬, 李晨. 南京市复治涂阳肺结核患者耐药状况分析[J]. 预防医学, 2019, 31(5): 478-481.
[4] 罗学辉, 黄邵军, 张建群, 杨元斌. 余姚市鼠伤寒沙门菌耐药性分析[J]. 预防医学, 2019, 31(5): 484-487.
[5] 岳永宁, 范大鹏, 张艳, 陈园园, 鲍志坚, 朱敏. 三种结核分枝杆菌分子检测技术诊断肺结核比较[J]. 预防医学, 2019, 31(5): 537-540.
[6] 刘立宾, 潘爱珍, 王静, 李浩, 岳永宁, 朱敏. T-SPOT.TB和SAT-TB联合检测诊断涂阴肺结核[J]. 预防医学, 2019, 31(4): 426-429.
[7] 单志力, 李君, 逄颖鑫, 毛玲琼, 朱小梅. 温州市耐多药/耐利福平肺结核空间聚集性分析[J]. 预防医学, 2019, 31(3): 242-245.
[8] 贾庆军, 谢立, 吴亦斐, 王乐, 陆敏, 赵刚. 杭州市结核病患者耐药检测结果分析[J]. 预防医学, 2019, 31(3): 289-292.
[9] 曾松芳,韩安棣,郭美丽,陈维增,陈阿德. 苍南县75株医院感染耐碳青霉烯类鲍曼不动杆菌耐药基因分析[J]. 预防医学, 2019, 31(11): 1131-1135.
[10] 王华, 田昌伟, 王文明, 滕国兴. 应用SARIMA-GRNN组合模型分析肺结核流行的季节性特征[J]. 预防医学, 2019, 31(1): 55-58.
[11] 张艳秋, 张国龙, 蒋建国, 王前, 王侃, 孟澜涛, 李栋梁. 河南省肺结核患者门诊诊疗费用分析[J]. 预防医学, 2019, 31(1): 85-88.
[12] 杨晓芳,谢建华,章秋霞. 下呼吸道感染主要病原菌耐药性分析[J]. 预防医学, 2018, 30(9): 930-932.
[13] 储文杰,金凯玲,林凯,单欢,陈伟国. 基于ARIMA乘积季节模型预测产超广谱β-内酰胺酶大肠埃希菌流行趋势研究[J]. 预防医学, 2018, 30(7): 680-684.
[14] 徐红,李琦,来优统,陈鸿达. 萧山区学生肺结核流行病学特征分析[J]. 预防医学, 2018, 30(6): 598-599.
[15] 卢巧玲,方益荣,孙佳美,高华强. 一起中学生肺结核聚集性疫情流行病学调查[J]. 预防医学, 2018, 30(6): 616-617.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed